NDAINJECTIONINJECTABLE
Approved
May 1949
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
AQUASOL A (water-miscible retinyl palmitate) by R-Pharm US is clinical pharmacology beta-carotene, retinol, and retinal have effective and reliable vitamin a activity. First approved in 1949.
Drug data last refreshed 15h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AQUASOL A is a water-miscible injectable formulation of retinyl palmitate (vitamin A) indicated for vitamin A deficiency and xerophthalmia. It works by restoring retinol levels necessary for visual function, growth, and epithelial cell integrity. The drug is absorbed via the GI tract and stored in the liver as retinyl palmitate for long-term vitamin A homeostasis.
LOE Approaching
Product approaching loss of exclusivity with minimal commercial momentum; brand team likely focused on cost management and niche indication preservation rather than growth initiatives.
Mechanism of Action
CLINICAL PHARMACOLOGY Beta-carotene, retinol, and retinal have effective and reliable vitamin A activity. Retinal and retinol are in chemical equilibrium in the body and have equivalent antixerophthalmic activity. Retinal combines with the rod pigment, opsin, in the retina to form rhodopsin,…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on AQUASOL A offers limited career advancement; the product is in late-stage lifecycle with no linked job postings and mature market dynamics. Roles are defensive in nature, focused on regulatory maintenance, cost containment, and compliance rather than commercial growth or innovation.
Worked on AQUASOL A at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.